Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,537.4
9.0 (0.36%)

 

  • STI Straits Times Index
    2,537.4
    9.0 (0.36%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,494.6
    -4.2 (-0.28%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,918.8
    132.6 (0.54%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,278.0
    -34.5 (-1.04%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,516.6
    42.3 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,112.2
    20.4 (0.40%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,104.8M
  • Value: 912.5M
  • Rise: 124
  • Fall: 150
  • Unch: 504

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.085-
Sembcorp Marine0.137-0.002
QT Vascular0.010+0.002
Spackman0.006-
Pan Asian0.047-
Singtel2.120+0.010
OEL0.019-
Mapletree Log Tr2.050-0.070
Suntec Reit1.460-0.010
Samko Timber0.037+0.001

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 23 Oct 2020 17:27
Last (SGD): 1.140 Change: -0.040 High: 1.180 Remarks: -
Change (%): -3.39 Low: 1.120
Open 1.170 Yesterday's Close 1.180
Buy Price 1.130 Sell Price 1.140
Buy Volume ('000) 405.2 Sell Volume ('000) 76.4
Cumulative Volume ('000) 6,038.7 Cumulative Value 6,922,443
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00285 Trailing EPS (SGD) e 0.10052 NAV (SGD) b 0.2571
PE a 400.000 Trailing PE f 11.341 Price / NAV b 4.4341
Dividend (SGD) d - Cash In Hand (SGD) g 0.0525 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 21.714 Treasury Shares h -
Beta - 75 Daysi 2.096 R-Squared - 75 Days(%)i 3.11 Market Cap (M) 626.329
Beta - 500 Daysi -0.125 R-Squared - 500 Days (%)i 0.01 Enterprise Value (M) 654.032
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 147.2157 6-Month VWAP 0.742 Free Float (%) 100.0
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 14 Oct 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 626.329 400.000 11.341 4.4341 -
Industry Medical & Biotechnology SGX 905.455 21.542 20.796 1.2894 2.120
Medical Specialties SGX 4,126.446 40.361 36.965 13.1486 1.270
Index FTSE ST Catalist Index SGX 64.361 30.063 88.683 1.1077 1.721
Local Peer Top Glove SGX 23,209.896 38.229 38.228 14.2714 1.349
Local Peer UGHealthcare SGX 559.631 41.762 41.757 7.8448 0.250
Local Peer Biolidics SGX 83.175 - - 7.7206 -
Local Peer Yunnan Energy SGX 35.531 - - 0.7346 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Global Peer ABBOTT LABORATORIES NYSE 190,845.429 52.058 56.952 - 1.219
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 189,949.970 51.393 38.932 5.9688 0.160
Global Peer DANAHER CORP NYSE 165,276.313 66.408 53.057 4.7639 0.286
Global Peer MEDTRONIC PLC NYSE 149,794.162 31.279 33.952 2.9783 1.934
Global Peer INTUITIVE SURGICAL INC NASDAQ 86,459.351 62.684 82.100 9.3391 -
Global Peer STRYKER CORP NYSE 83,346.971 40.013 52.059 6.5350 0.959
Global Peer BECTON DICKINSON & CO NYSE 69,649.723 64.371 89.987 2.8997 1.196
Global Peer BOSTON SCIENTIFIC CORP NYSE 53,178.004 11.314 13.361 3.4053 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 49,994.194 47.755 62.957 11.8742 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 45,643.755 34.945 40.966 3.7106 1.825
Other Global Peers BAXTER INTERNATIONAL INC (NYSE), DEXCOM INC (NASDAQ), ALIGN TECHNOLOGY INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), HOLOGIC INC (NASDAQ), BIO RAD LABORATORIES INC (NYSE), TOPGLOV (Bursa), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), INSULET CORPORATION (NASDAQ), STERIS PLC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), HARTA (Bursa), PERKINELMER INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), WATERS CORP (NYSE), MASIMO CORPORATION (NASDAQ), ABIOMED INC (NASDAQ), NOVOCURE LTD (NASDAQ), QIAGEN NV (NYSE), DENTSPLY SIRONA INC (NASDAQ), COCHLEAR LTD (ASX), QUIDEL CORP (NASDAQ), WEIGAO GROUP (HKEx), PENUMBRA INC (NYSE), TANDEM DIABETES CARE INC (NASDAQ), MICROPORT (HKEx), BRUKER CORPORATION (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), SUPERMX (Bursa), NEVRO CORP (NYSE), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), VENUS MEDTECH-B (HKEx), NEOGEN CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), KANGJI MEDICAL (HKEx), INARI MEDICAL INC (NASDAQ), EBOS GROUP (ASX), MERIT MEDICAL SYSTEMS (NASDAQ), AK MEDICAL (HKEx), NUVASIVE INC (NASDAQ), GLAUKOS CORPORATION (NYSE), LIVANOVA PLC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), CONMED CORP (NYSE), PEIJIA-B (HKEx), CANTEL MEDICAL CORP (NYSE), SILK ROAD MEDICAL INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), AVANOS MEDICAL INC (NYSE), ATRICURE INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOTELEMETRY INC (NASDAQ), INMODE LTD (NASDAQ), PULMONX CORPORATION (NASDAQ), MESA LABORATORIES INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), ATRION CORP (NASDAQ), NANOSONICS LIMITED (ASX), HESKA CORP (NASDAQ), CIRC (HKEx), LIFETECH SCI (HKEx), ORASURE TECHNOLOGIES INC (NASDAQ), KDL MEDICAL (HKEx), CERUS CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), VERICEL CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), VAPOTHERM INC (NYSE), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), CRYOLIFE INC (NYSE), ACUTUS MEDICAL INC (NASDAQ), SI BONE INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), INOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), INFUSYSTEM HOLDINGS INC (NYSE American), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), AXOGEN INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), ZYNEX INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), QUOTIENT LTD (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), SEASPINE HOLDINGS CORP (NASDAQ), YESTAR HEALTH (HKEx), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), CYTOSORBENTS CORP (NASDAQ), CORMEDIX INC (NYSE American), PROFOUND MED CORP (NASDAQ), PW MEDTECH (HKEx), AROA BIOSURGERY LTD (ASX), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), IRADIMED CORP (NASDAQ), RETRACTABLE TECHNOLOGIES INC (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), DERMTECH INC (NASDAQ), STEREOTAXIS INC (NYSE American), INVACARE CORP (NYSE), TELA BIO INC (NASDAQ), SIENTRA INC (NASDAQ), ALPHA PRO TECH (NYSE American), MISONIX INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SOLITON INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), MODERN DENTAL (HKEx), VINCENT MED (HKEx), BIOSIG TECHNOLOGIES INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), FONAR CORP (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), INTRICOM CORP (NASDAQ), CYCLOPHARM LIMITED (ASX), CLEARPOINT NEURO INC (NASDAQ), LKL (Bursa), NEURONETICS INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), PAVMED INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), RESPIRI LTD (ASX), ROCKWELL MEDICAL INC (NASDAQ), LENSAR INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), VOLITIONRX LIMITED (NYSE American), BELLEROPHON THERAPEUTICS INC (NASDAQ), ELECTROMED INC (NYSE American), ELECTROCORE INC (NASDAQ), SDI LTD (ASX), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEPHROS INC (NASDAQ), BIOMERICA INC (NASDAQ), CONFORMIS INC (NASDAQ), RESAPP HEALTH LIMITED (ASX), IMPEDIMED LIMITED (ASX), INCANNEX HEALTHCARE LTD (ASX), DAXOR CORP (NYSE American), MILESTONE SCIENTIFIC INC (NYSE American), TITAN MEDICAL INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), COMPUMEDICS (ASX), MICRO-X LTD (ASX), ONCOCYTE CORP (NYSE American), RESONANCE HEALTH LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), STRATA SKIN SCIENCES INC (NASDAQ), OPTISCAN IMAGING (ASX), DELCATH SYSTEMS INC (NASDAQ), NEOVASC INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), APPLIED UV INC (NASDAQ), IMMUCELL CORP (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), KELFRED (HKEx), DIMERIX LTD (ASX), ZOSANO PHARMA CORP (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), LIFE HEALTH-NEW (HKEx), CARDIEX LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), BIOLASE INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), METALICITY LIMITED (ASX), OVENTUS MEDICAL LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), REWALK ROBOTICS LTD (NASDAQ), LBT INNOVATIONS LTD (ASX), AVINGER INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CELSION CORPORATION (NASDAQ), AETHLON MEDICAL INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), USCOM LTD (ASX), AKERS BIOSCIENCES INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), CYANOTECH CORP (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE), THERMOGENESIS HOLDINGS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), DIGIRAD CORP (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), ALLEGRA ORTHOPAEDICS LIMITED (ASX), LIANLUO SMART LIMITED (NASDAQ), ADHERIUM LIMITED (ASX), DYNATRONICS CORP (NASDAQ), CANCER GENETICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), ANALYTICA (ASX), OBALON THERAPEUTICS INC (NASDAQ), NEUROTECH INTERNATIONAL LTD (ASX), DORSAVI LTD (ASX), NEUROMETRIX INC (NASDAQ), HUAKANG BIOMED (HKEx), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.180
-13.64 %
10 Days --0.080
-6.56 %
20 Days --0.080
-6.56 %
Medium Term Return 3 Months 0.012+0.390
+53.60 %
6 Months 0.012+1.024
+893.10 %
1 Year 0.012+1.107
+3390.91 %
Long Term Return 2 Years 0.012+1.108
+3500.00 %
3 Years 0.012+1.090
+2204.00 %
5 Years 0.012+1.086
+2033.33 %
Annualised Return Annualised --
+84.42 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.031 - 1.980 Change From 1 Year Low +1.109 % Change From 1 Year Low (%) +3577.42
Change From 1 Year High -0.840 % Change From 1 Year High (%) -42.42
2 Years Range 0.022 - 1.980 Change From 2 Years Low +1.118 % Change From 2 Years Low (%) +5081.82
Change From 2 Years High -0.840 % Change From 2 Years High (%) -42.42
5 Years Range 0.022 - 1.980 Change From 5 Years Low +1.118 % Change From 5 Years Low (%) +5081.82
Change From 5 Years High -0.840 % Change From 5 Years High (%) -42.42
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) +354.18 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.04 MB)
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
23 Oct 2020 1.170 1.180 1.120 1.140 6,038,700 1.1463
22 Oct 2020 1.190 1.210 1.100 1.180 20,292,500 1.1523
21 Oct 2020 1.280 1.310 1.180 1.190 30,949,900 1.2337
20 Oct 2020 1.310 1.310 1.250 1.270 10,472,000 1.2725
19 Oct 2020 1.330 1.360 1.250 1.290 15,995,600 1.3051
16 Oct 2020 1.270 1.340 1.260 1.320 24,299,400 1.3062
15 Oct 2020 1.340 1.380 1.220 1.250 39,997,800 1.2983
14 Oct 2020 1.560 1.590 1.310 1.360 75,634,300 1.4859
13 Oct 2020 1.440 1.530 1.420 1.480 48,742,800 1.4668
12 Oct 2020 1.230 1.420 1.220 1.420 41,353,700 1.3279
09 Oct 2020 1.200 1.250 1.200 1.220 14,444,200 1.2255
08 Oct 2020 1.200 1.220 1.190 1.200 5,962,300 1.2002
07 Oct 2020 1.190 1.210 1.180 1.190 5,602,000 1.1907
06 Oct 2020 1.240 1.250 1.170 1.190 13,761,500 1.2041
05 Oct 2020 1.210 1.260 1.190 1.220 33,351,000 1.2263
02 Oct 2020 1.110 1.190 1.090 1.180 25,372,800 1.1570
01 Oct 2020 1.110 1.150 1.080 1.110 10,120,600 1.1125
30 Sep 2020 1.120 1.160 1.060 1.080 12,144,800 1.1077
29 Sep 2020 1.220 1.230 1.100 1.120 26,063,500 1.1508
28 Sep 2020 1.210 1.250 1.210 1.220 8,389,000 1.2279
25 Sep 2020 1.230 1.270 1.210 1.220 11,670,600 1.2383
24 Sep 2020 1.260 1.270 1.210 1.230 18,004,800 1.2456
Summary
Current 2 Weeks
(12 Oct 2020 to 23 Oct 2020)
1.230 1.590 1.100 1.140 313,776,700 -
Previous 2 Weeks
(28 Sep 2020 to 09 Oct 2020)
1.210 1.590 1.100 1.220 155,211,700 -
4 Weeks from
(31 Aug 2020 to 25 Sep 2020)
1.530 1.610 1.100 1.220 460,452,600 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.